| 释义 |
topo·isom·er·ase 英ˌtɒpɔɪ'sʌməreɪz美ˌtɒpɔɪ'sʌməreɪz BNC⁹⁷²³³⁺⁷
基本例句
n.化拓扑异构酶
In addition, the paper reviewed screening methods for differentiation inducers, DNA topoisomerase inhibitors, antimicrotubule drugs and biological response modifiers.
还对分化诱导剂、拓扑异构酶抑制剂、抗微管药和生物反应调节剂的筛选方法进行了评述。 cnki
The specific activity of topoisomerase I was higher in proliferating tissues and much higher in malignant tissues than that in differentiated tissues.
发现增殖组织全细胞抽提液中酶比活高于正常分化组织，而且在异常增殖组织中酶比活的增高更为显著。 cnki
Conclusion: The mouse TFAR19 sequence is highly homologous with human TFAR19 and may have functional relationship with DNA topoisomerase I.
结论：小鼠 TFAR19是与人 TFAR19高度同源的新基因，与 DNA拓扑异构酶 I可能有功能相关性。 cnki
Irinotecan is the specific inhibitor of topoisomerase I.
伊立替康是拓扑异构酶 I的特异性抑制剂。 chemyq
Mutation of type II topoisomerase gene;
拓扑异构酶 II基因突变； chemyq
Objective To study the effects of some biochemical factors on apoptosis in nasopharyngeal carcinoma cellsCEN-2Z induced by DNA topoisomerase I inhibitor camptothecin CPT.
目的研究有关生化因素对喜树碱 CPT诱导人鼻咽癌细胞凋亡的影响。 cnki
Purpose To investigate the relationship between DNA topoisomerase and cell proliferation, apoptosis in ovarian carcinomas.
目的：探讨 DNA拓扑异构酶在卵巢浆液性、黏液性囊腺癌中的表达及与细胞增殖、凋亡的关系。 cnki |